Your browser doesn't support javascript.
loading
CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS.
Rösler, Wiebke; Bink, Andrea; Bissig, Marina; Imbach, Lukas; Marques Maggio, Ewerton; Manz, Markus G; Müller, Thomas; Roth, Patrick; Rushing, Elisabeth; Widmer, Corinne; Zenz, Thorsten; von Moos, Seraina; Müller, Antonia M S.
Affiliation
  • Rösler W; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
  • Bink A; Department of Neuroradiology, University Hospital Zurich, Switzerland.
  • Bissig M; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
  • Imbach L; Department of Neurology, University Hospital Zurich, Switzerland.
  • Marques Maggio E; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland.
  • Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
  • Müller T; Department of Nephrology, University Hospital Zurich, Switzerland.
  • Roth P; Department of Neurology, University Hospital Zurich, Switzerland.
  • Rushing E; Institute of Neuropathology, University Hospital Zurich, Switzerland.
  • Widmer C; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
  • Zenz T; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
  • von Moos S; Department of Nephrology, University Hospital Zurich, Switzerland.
  • Müller AMS; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
Hemasphere ; 6(7): e733, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35747591

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2022 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2022 Document type: Article Affiliation country: Switzerland